Eastern Europe Vitamin K2 Market, by Application

Growth Outlook

• The Eastern Europe Vitamin K2 Market, by Application market is on a steady long-term growth path. Segment value stands at roughly USD 46 Mn in 2026 and is projected to reach USD 65 Mn by 2027 — a gain of about 41% over the forecast period, translating to a CAGR in the double digits.
• Nutraceutical and Food is the biggest of 2 groups as of 2027, at 54. 01M USD (83% of the combined total).
• What the regional split looks like (2026): Nutraceutical and Food leads, holding roughly 83% of segment value — the single largest regional share. Pharmaceutical is the second-largest contributor.
• By 2027, Nutraceutical and Food alone is expected to reach USD 54 Mn, with Pharmaceutical at USD 11 Mn.

Market Dynamics

Nutraceutical and Food is the biggest of 2 groups as of 2027, at 54.01M USD (83% of the combined total).

Second place: Pharmaceutical, 11.08M USD, trailing Nutraceutical and Food by 79%.

Nutraceutical and Food grows to 54.01M USD by 2027, from 3.04M USD in 2018 — 1677% up.

Pharmaceutical: up 2031% over the period, 520.00K USD to 11.08M USD.

By rate of change, not size, Pharmaceutical is the standout — 2031% growth, faster than the rest of the group.

Across the full group, the combined total moves from 3.56M USD in 2018 to 65.09M USD in 2027 — a 1728% change.

Reading A Multi-Series Chart

This is a comparison chart, 2 groups at once — the interesting question is usually how the gap between them changes, not the value of any single group in isolation.

Do not confuse "biggest" with "fastest-growing" — they are frequently different series on a chart like this one, and the gap between them can close faster than the current ranking suggests.

The most practical way to read this is relative: set the Eastern Europe Vitamin K2 market figures beside other regions or segments of the same market to see where growth is concentrated.

Figures before the 2018 base year are historical estimates; the years through 2027 are projections built from industry data, company revenues, and primary interviews. Forecasts are revised as new data comes in, so check the full report for the latest assumptions.